Peptidoglycan D-Ala-D-Ala moiety

The **Peptidoglycan D-Ala-D-Ala moiety** is a highly conserved structural feature found at the terminal end of the peptide stems in nascent peptidoglycan precursors within most bacteria. Peptidoglycan itself is a mesh-like polymer composed of alternating N-acetylglucosamine and N-acetylmuramic acid sugars cross-linked by short peptides. The canonical pentapeptide stem typically ends with two consecutive D-alanine residues—D-alanyl-D-alanine—which serve as critical substrates for transpeptidase enzymes (penicillin-binding proteins) that catalyze cross-linking between adjacent glycan chains during cell wall biosynthesis[1][5][6]. This cross-linking confers mechanical strength and shape stability to the bacterial cell. The **D-Ala-D-Ala motif** is also recognized as a key target for several classes of antibiotics, most notably glycopeptides such as vancomycin. These drugs bind directly to this dipeptide sequence, sterically hindering access by PBPs and thus inhibiting proper assembly of the peptidoglycan network[2]. Resistance can arise when bacteria alter this terminal sequence—for example, replacing it with D-alanyl-D-lactate—thereby reducing antibiotic binding affinity. This structural motif does not exist in human cells but is essential for most pathogenic bacteria; therefore, it represents an important therapeutic target in infectious disease treatment strategies[1][2].

Other names

D-alanyl-D-alanine motifD-Ala-D-Ala dipeptidepeptidoglycan pentapeptide terminuscell wall precursor terminal dipeptide

Inhibition of transpeptidation/cross-linking by binding to the D-Ala-D-Ala terminus and blocking access to penicillin-binding proteins (PBPs), thereby preventing proper cell wall synthesis and leading to bacterial lysis[2][4].